Background: Historical data suggesting poor survival in patients with aortic stenosis (AS)
who do not undergo treatment are largely confined to patients with severe AS. Objectives …

Background Pulmonary hypertension (PHT) lacks community prevalence and outcome data.
Objective To characterise minimum 'indicative'prevalences and mortality data for all forms of …

Current guidelines recommend that clinical surveillance for patients with moderate aortic
stenosis (AS) and aortic valve replacement (AVR) may be considered if there is an indication …

A virtual workshop was organized by the Heart Valve Collaboratory to identify areas of
expert consensus, areas of disagreement, and evidence gaps related to bioprosthetic aortic …

Pulmonary hypertension is a progressive and often fatal disease that frequently presents
with dyspnoea on exertion and results in increased right ventricular afterload and right …

Aims To examine the characteristics/prognostic impact of diastolic dysfunction (DD)
according to 2016 American Society of Echocardiography (ASE) and European Society of …

Aims We investigated the sex‐based risk of mortality across the spectrum of left ventricular
ejection fraction (LVEF) in a large cohort of patients in Australia. Methods and results …

Objectives: The goal of this study was to characterize a variant in the SCN5A gene that
encodes the alpha-subunit of the cardiac sodium channel, Nav1. 5, which was identified in 1 …

Background: There is increasing evidence that current thresholds for diagnosing pulmonary
hypertension (PHT) underestimate the prognostic impact of PHT. Objectives: The aim of this …

Background: We sought to determine the prevalence of pulmonary complications and
especially pulmonary arterial hypertension (PAH) in an Australian scleroderma population …